Dr. Martens (LON:DOCS – Get Free Report) posted its earnings results on Thursday. The company reported GBX (0.90) earnings per share (EPS) for the quarter, Digital Look Earnings reports. Dr. Martens had a net margin of 7.89% and a return on equity of 18.91%.
Dr. Martens Stock Performance
DOCS traded down GBX 8.30 on Thursday, reaching GBX 73.30. The stock had a trading volume of 3,471,385 shares, compared to its average volume of 2,198,401. The business’s 50-day moving average price is GBX 90.64 and its two-hundred day moving average price is GBX 80.35. The company has a market cap of £708.32 million, a P/E ratio of 146.60, a price-to-earnings-growth ratio of 6.40 and a beta of 0.11. Dr. Martens has a 12-month low of GBX 43.02 and a 12-month high of GBX 100.87. The company has a current ratio of 2.85, a quick ratio of 1.13 and a debt-to-equity ratio of 127.27.
Insider Activity
In other news, insider Ije Nwokori sold 298,675 shares of the business’s stock in a transaction that occurred on Wednesday, October 15th. The stock was sold at an average price of GBX 90, for a total value of £268,807.50. Also, insider Giles Wilson bought 105,838 shares of Dr. Martens stock in a transaction dated Monday, September 1st. The shares were acquired at an average cost of GBX 91 per share, with a total value of £96,312.58. In the last 90 days, insiders purchased 136,960 shares of company stock valued at $12,460,163 and sold 434,460 shares valued at $39,131,400. 2.80% of the stock is owned by insiders.
Analyst Ratings Changes
Read Our Latest Research Report on Dr. Martens
About Dr. Martens
Founded in 1960, Dr. Martens is an iconic British brand with a global presence. “Docs” or “DMs” were originally
produced for their durability for workers, before being adopted by diverse youth subcultures and associated musical
movements. Today, Dr. Martens has transcended its roots while still celebrating its proud history.
Read More
- Five stocks we like better than Dr. Martens
- What is a SEC Filing?
- NVIDIA Just Proved the AI Boom Is Bigger Than Anyone Thought
- What Do S&P 500 Stocks Tell Investors About the Market?
- Why Target Stock May Keep Falling Despite a 5% Dividend Yield
- Find and Profitably Trade Stocks at 52-Week Lows
- Is Tesla Setting Up for a Year-End Rebound—or a Collapse?
Receive News & Ratings for Dr. Martens Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dr. Martens and related companies with MarketBeat.com's FREE daily email newsletter.
